Leaflet REMAVIR 50mg tablets

Product code:
W63703001
Quantity:
20
Indicated for:
viral infections
Route of administration:
oral
Substance:
rimantadine (antiviral)
ATC
J05AC02 — Antiinfectives for systemic use | Direct acting antivirals | Cyclic amines

Precautions:

Dose adjustment in renal impairment

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Rimantadine is an antiviral medication used for the prevention and treatment of infections caused by influenza A virus. It works by inhibiting viral replication, reducing the severity and duration of symptoms.

The medication is taken orally, as directed by a doctor, usually once or twice daily. It is important for patients to start treatment as soon as possible after symptom onset to achieve maximum effectiveness.

Patients should be aware of potential side effects, such as nausea, dizziness, or insomnia. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, dizziness, and insomnia. In rare cases, severe reactions such as allergic reactions or neurological disturbances may occur. Patients should be informed of these risks before starting treatment.

General data about REMAVIR 50mg

Substance:
rimantadine
Date of latest medicines list:
16-08-2017
Product code:
W63703001
Concentration:
50mg
Pharmaceutical form:
tablets
Quantity:
20
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.